Dubai has decided to age slower — as national strategy. Longevium Health is the science bet behind that decision: a longevity R&D program in Dubai, built on the Longevium clinical network and a planned AI Research Center. Seven projects, one roadmap.
Western medicine waits for something to break and then bills for the repair. Longevium Health is built on a different bet: biological age is a number you can move, and ageing is an engineering problem. Dubai has already made that bet national strategy — our job is to turn it into a concrete R&D agenda.
The core is regenerative medicine and preventive diagnostics: peptide protocols, exosomes, evidence-based methods of slowing ageing. We are building our own pipeline of peptide protocols and evaluating a compounding pharmacy model as a way to bring them to the clinic faster than the market. AI is used to prioritize molecules and biomarkers before synthesis.
Early diagnostics is the core of preventive longevity medicine: catch the problem before it becomes disease. Everything we develop is measured on our own patients first, and only then moves further.
A xenon and argon research platform spanning geroprotection, organ protection and neuroinflammation, with potential clinical protocols for stress, chronic pain and addiction. The next step is selecting the first protocol and UAE regulatory route.
We are developing a preventive outpatient hemoadsorption protocol targeting systemic inflammation. The method removes endotoxins and excess cytokines; the clinical protocol and economics for Longevium programs are now under review.
A retrospective analysis of Longevium patient data and biomarkers to build and validate a biological age model, identify the most informative markers of ageing and create the foundation for personalized programs.
A monitoring, analysis and sleep-correction ecosystem linked to clinical protocols. The first prototype is a screen-free alarm with a tactile surface that gradually warms toward wake-up time.
An AI neuro-immersive capsule where panoramic screens, music, light and vibration create a personal environment for rest, focus and neurofeedback. EEG and sensors measure the response and adapt the experience in real time.
Robotic contactless body scanning creates a digital profile: 3D body model, anthropometry, posture, skin and surface-temperature maps. The goal is a reproducible examination that makes changes precisely comparable over time.
A digital twin combining health history, examinations and biomarkers to model personal scenarios and estimate the likely effect of interventions. It builds on the biological age model and data from Orbit.
A doctor's AI assistant right in the browser. Reads the chart while the physician writes — on top of any EMR, no integrations. Cross-checks WHO, NICE, ESC, IDSA and ADA guidelines in real time.
Catches gaps, missed prescriptions, wrong antibiotics and forgotten follow-ups. Shows a live score across five clinical axes.
The patient uploads a unified health profile, computes biological age, plans visits and receives personal protocols.
One layer holds all data and the patient's protocol. Subscription revenue; research, doctors and clinic locking into one AI ecosystem — the first honest step toward a patient digital twin.
PhD, preventive medicine physician and vascular specialist with 14 years of clinical experience. Founder and CEO of Longevium — a longevity clinic ecosystem in Dubai: 3 clinics, 30,000+ patients, 10,000+ trained physicians.
Bridges clinical practice and strategy: develops proprietary protocols in metabolic health, hormones, GLP-1, peptide and regenerative medicine. Sets the scientific agenda of Longevium Health and the Longevium AI Research Center.
"Health is not reactive care. It is engineered longevity."
Professor at the American University of Sharjah (AUS), biomedical engineer and innovator with training at MIT, working at the intersection of longevity, precision health, regenerative medicine, microfluidics and AI-enabled healthcare.
Member of the Geneva College of Longevity Science (GCLS), deeply committed to advancing evidence-based longevity science, educating and inspiring the next generation of scientists, clinicians and entrepreneurs, and expanding global awareness and adoption of precision and preventive health.
His broader vision is to connect cutting-edge research, emerging technologies and education to help shift healthcare from reactive treatment toward personalized prevention, healthier ageing and longer healthspan.
How Dubai is becoming the hub of the next healthcare wave — featuring Longevium and its approach to extending healthspan.
A review of Dubai's longevity market and Longevium's stance: evidence-based medicine over anti-ageing marketing.
Longevium physicians comment on the proper use of tumour markers within early cancer detection programs.
Longevium is recognized as a Longevity Spot by Longevity Germany — an independent European registry of evidence-based longevity clinics.
While Western regulators hold hearings, MENA holds appointments. Longevium Health builds on the Longevium clinical network in Dubai and its own R&D agenda. If you're developing a technology, device, biomarker or AI solution in longevity — we bring the clinical venue, patients and partner infrastructure to validate it here and reach MENA ahead of your competitors.
